Kayvon Modjarrad

1. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
   2019/07/24 by Kayvon Modjarrad, Christine C Roberts, Christine C. Roberts +53 · 5 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Intramuscular injections and effects #SARS-CoV-2 and COVID-19 Research #vaccines and immunoinformatics approaches
2. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
   2017/12/05 by Kayvon Modjarrad, Leyi Lin, Sarah L George +59 · 2 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Immune responses and vaccinations #Mosquito-borne diseases and control #vaccines and immunoinformatics approaches